Consensus on acromegaly therapeutic outcomes: an update
Por:
Melmed, S, di Filippo, L, Fleseriu, M, Mercado, M, Karavitaki, N, Gurnell, M, Salvatori, R, Tsagarakis, S, Losa, M, Maffei, P, Pereira, AM, Geer, EB, Katznelson, L, van der Lely, AJ, Bollerslev, J, Esposito, D, Webb, SM, Zatelli, MC, Valassi, E, Neggers, S, Chanson, P, Ho, KKY, Ioachimescu, AG, Biller, BMK, Samson, SL, Kaiser, UB, Schilbach, K, Luque, RM, Casanueva, FF, Shimon, I, Boguszewski, CL, Biermasz, N, Colao, A, Pirchio, R, Lamberts, SWJ, Kadioglu, P, Buchfelder, M, Frara, S, Chiloiro, S, Petersenn, S, Gadelha, MR, Puig-Domingo, M, Luger, A, Brue, T, Beckers, A, Ferone, D, Clemmons, DR, Greenman, Y, Marazuela, M, Mortini, P, Strasburger, CJ and Giustina, A
Publicada:
1 nov 2025
Ahead of Print:
1 ago 2025
Resumen:
The 15th Acromegaly Consensus Conference in September 2023 updated recommendations on therapeutic outcomes for acromegaly. Since the publication of medical management guidelines in 2018, new pharmacological agents and new treatment approaches have been developed. Fifty-two experts in the management of acromegaly reviewed the current literature and assessed changes in drug approvals, clinical practice standards and management. Current outcome goals were considered, with a focus on the effect of current and emerging somatostatin receptor ligands, the growth hormone receptor antagonist pegvisomant and the dopamine agonist cabergoline on biochemical control, clinical control, adenoma mass and surgical outcomes. Participants assessed factors that determine pharmacological choices, as well as the proposed use of each agent. Here, we present consensus recommendations highlighting how an evidence-based acromegaly management algorithm could be optimized in clinical practice.
Filiaciones:
Melmed, S:
Cedars Sinai Med Ctr, Los Angeles, CA USA
di Filippo, L:
Univ San Raffaele Vita Salute, IRCCS Osped San Raffaele, Inst Endocrine & Metab Sci, Milan, Italy
Fleseriu, M:
Oregon Hlth & Sci Univ, Pituitary Ctr, Med & Neurol Surg, Portland, OR 97201 USA
Mercado, M:
Inst Mexicano Seguro Social, Hosp Especial, Ctr Med Nacl Siglo 21, Endocrine Res Unit, Mexico City, Mexico
Karavitaki, N:
Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Dept Endocrinol, Birmingham, Warwick, England
Univ Birmingham, Sch Med & Hlth, Dept Metab & Syst Sci MSS, Birmingham, England
Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, England
Gurnell, M:
Univ Cambridge, Inst Metab Sci, Metab Res Labs, Cambridge, England
Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Cambridge, England
Salvatori, R:
Johns Hopkins Univ, Dept Med, Div Endocrinol, Baltimore, MD USA
Johns Hopkins Univ, Pituitary Ctr, Baltimore, MD USA
Tsagarakis, S:
Evangelismos Med Ctr, Natl Expertise Ctr Rare Endocrine Disorders, Dept Endocrinol Diabet & Metab, Athens, Greece
Losa, M:
Univ Vita Salute San Raffaele, IRCCS Osped San Raffaele, Dept Neurosurg & Gamma Knife Radiosurg, Milan, Italy
Maffei, P:
Univ Padua, Dept Med, Padua, Italy
Pereira, AM:
Univ Amsterdam, Amsterdam UMC, Dept Endocrinol & Metab, Amsterdam Gastroenterol Endocrinol & Metab, Amsterdam, Netherlands
Geer, EB:
Mem Sloan Kettering Canc Ctr, Multidisciplinary Pituitary & Skull Base Tumour Ct, Dept Med, New York, NY USA
Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY USA
Katznelson, L:
Stanford Univ, Sch Med, Dept Med, Div Endocrinol, Stanford, CA 94305 USA
van der Lely, AJ:
Erasmus MC, Pituitary Ctr Rotterdam, Rotterdam, Netherlands
Erasmus MC, Dept Med, Rotterdam, Netherlands
Bollerslev, J:
Med Clin Oslo Univ Hosp, Sect Specialized Endocrinol, Oslo, Norway
Esposito, D:
Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden
Sahlgrens Univ Hosp, Dept Endocrinol, Gothenburg, Sweden
Webb, SM:
Hosp S Pau, Inst Recerca St Pau IIB St Pau, Res Ctr Pituitary Dis, Endocrinol, Barcelona, Spain
Univ Autonoma Barcelona, Dept Med, CIBERER Unit 747, Barcelona, Spain
Zatelli, MC:
Univ Ferrara, Dept Med Sci, Sect Endocrinol Geriatr & Internal Med, Ferrara, Italy
:
Germans Trias i Pujol Hosp & Res Inst, Endocrinol Dept, Barcelona, Spain
Ctr Invest Biomed Red Enfermedades Raras, CIBERER Unit 747, Barcelona, Spain
Univ Int Catalunya UIC, Sch Med, Barcelona, Spain
Neggers, S:
Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
Chanson, P:
Univ Paris Saclay, Hop Bicetre, Assistance Publ Hop Paris,Serv Endocrinol Malad Re, Inserm,Physiol & Physiopathol Endocriniennes, Le Kremlin Bicetre, France
Univ Paris Saclay, Hop Bicetre, Assistance Publ Hop Paris, Ctr Reference Malad Rares Hypophyse HYPO, Le Kremlin Bicetre, France
Ho, KKY:
UNSW Sydney, St Vincents Hosp, Garvan Inst Med Res, Sydney, NSW, Australia
Ioachimescu, AG:
Med Coll Wisconsin, Div Endocrinol & Mol Med, Milwaukee, WI USA
Biller, BMK:
Massachusetts Gen Hosp, Neuroendocrine & Pituitary Tumor Clin Ctr, Boston, MA USA
Samson, SL:
Mayo Clin, Dept Med, Div Endocrinol Diabet & Metab, Jacksonville, FL USA
Kaiser, UB:
Harvard Med Sch, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA USA
Schilbach, K:
Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Med Klin & Poliklin 4, Munich, Germany
Luque, RM:
Univ Cordoba, Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain
Ctr Invest Biomed Red Fisiopatol Obes & Nutr CIBER, Cordoba, Spain
Casanueva, FF:
Santiago Compostela Univ, Inst Salud Carlos III, IDIS Complejo Hosp Univ Santiago CHUS, CIBER Fisiopatol Obes & Nutr CIBERobn, Santiago De Compostela, Spain
Shimon, I:
Rabin Med Ctr Petah Tikva, Beilinson Hosp, Inst Endocrinol, Tel Aviv, Israel
Tel Aviv Univ, Fac Med & Hlth Sci, Tel Aviv, Israel
Boguszewski, CL:
Univ Fed Parana, Univ Hosp, Dept Internal Med, Endocrine Div SEMPR, Curitiba, Brazil
Biermasz, N:
Leiden Univ Med Ctr, Ctr Endocrine Tumors Leiden, Dept Med, Div Endocrinol, Leiden, Netherlands
Colao, A:
Univ Federico II Napoli, Dipartimento Med Clin & Chirurg, Sez Endocrinol, Naples, Italy
Pirchio, R:
Univ Federico II Napoli, Dipartimento Med Clin & Chirurg, Sez Endocrinol, Naples, Italy
Lamberts, SWJ:
Erasmus MC, Dept Internal Med, Div Endocrinol, Rotterdam, Netherlands
Kadioglu, P:
Istanbul Univ, Dept Internal Med, Div Endocrinol Metab & Diabet, Istanbul, Turkiye
Buchfelder, M:
Univ Hosp Erlangen, Dept Neurosurg, Erlangen, Germany
Frara, S:
Univ San Raffaele Vita Salute, IRCCS Osped San Raffaele, Inst Endocrine & Metab Sci, Milan, Italy
Chiloiro, S:
Univ Cattolica Sacro Cuore, Dept Translat Med & Surg, Rome, Italy
Univ Hosp Agostino Gemelli, I-00168 Rome, Italy
Petersenn, S:
ENDOC Ctr Endocrine Tumors, Hamburg, Germany
Gadelha, MR:
Univ Fed Rio De Janeiro, Med Sch, Neuroendocrinol Res Ctr, Endocrinol Div, Rio De Janeiro, Brazil
Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil
:
Germans Trias i Pujol Univ Hosp, Dept Endocrinol & Nutr, Badalona, Spain
ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Unidad 747, Barcelona, Spain
Luger, A:
Med Univ Vienna, Dept Med 3, Clin Div Endocrinol & Metab, Vienna, Austria
Brue, T:
Aix Marseille Univ, AP HM, INSERM, MMG,MarMaRa, Marseille, France
La Conception Univ Hosp, Reference Ctr Rare Pituitary Dis CRMR HYPO, Dept Endocrinol, Marseille, France
Beckers, A:
Univ Liege, Ctr Hosp Liege, Dept Endocrinol, Domaine Univ Sart Tilman, Liege, Belgium
Ferone, D:
Univ Genoa, IRCCS,Osped Policlin San Martino, Dept Internal Med & Med Specialties, Endocrinol Unit, Genoa, Italy
Clemmons, DR:
Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA
Greenman, Y:
Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Endocrinol Diabet Metab & Hypertens, Tel Aviv, Israel
Marazuela, M:
Univ Autonoma Madrid, Hosp Univ La Princesa, Dept Endocrinol & Nutr, Inst Invest Sanitaria La Princesa, Madrid, Spain
Mortini, P:
Univ Vita Salute San Raffaele, IRCCS Osped San Raffaele, Dept Neurosurg & Gamma Knife Radiosurg, Milan, Italy
Strasburger, CJ:
Charite Univ Med Berlin, Dept Endocrinol & Metab, Berlin, Germany
Giustina, A:
Univ San Raffaele Vita Salute, IRCCS Osped San Raffaele, Inst Endocrine & Metab Sci, Milan, Italy
Green Accepted, Bronze
|